131 related articles for article (PubMed ID: 7516015)
1. Bradykinin accounts for improved postischemic function and decreased glutathione release of guinea pig heart treated with the angiotensin-converting enzyme inhibitor ramiprilat.
Massoudy P; Becker BF; Gerlach E
J Cardiovasc Pharmacol; 1994 Apr; 23(4):632-9. PubMed ID: 7516015
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide accounts for postischemic cardioprotection resulting from angiotensin-converting enzyme inhibition: indirect evidence for a radical scavenger effect in isolated guinea pig heart.
Massoudy P; Becker BF; Gerlach E
J Cardiovasc Pharmacol; 1995 Mar; 25(3):440-7. PubMed ID: 7769810
[TBL] [Abstract][Full Text] [Related]
3. Local inhibition of bradykinin degradation in ischemic hearts.
Linz W; Martorana PA; Schölkens BA
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
[TBL] [Abstract][Full Text] [Related]
4. Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril.
Linz W; Schölkens BA; Kaiser J; Just M; Qi BY; Albus U; Petry P
Cardiovasc Drugs Ther; 1989 Dec; 3(6):873-82. PubMed ID: 2535056
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide.
Ehring T; Baumgart D; Krajcar M; Hümmelgen M; Kompa S; Heusch G
Circulation; 1994 Sep; 90(3):1368-85. PubMed ID: 8087948
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment with ramiprilat induces cardioprotection against free radical injury in guinea-pig isolated heart: involvement of bradykinin, protein kinase C and prostaglandins.
Jin ZQ; Chen X
Clin Exp Pharmacol Physiol; 2000 Apr; 27(4):257-62. PubMed ID: 10779122
[TBL] [Abstract][Full Text] [Related]
7. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
Hartman JC
Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
[TBL] [Abstract][Full Text] [Related]
8. Effects of the angiotensin converting enzyme inhibitor, ramipril, in isolated ischaemic rat heart are abolished by a bradykinin antagonist.
Schölkens BA; Linz W; König W
J Hypertens Suppl; 1988 Dec; 6(4):S25-8. PubMed ID: 2853732
[TBL] [Abstract][Full Text] [Related]
9. Local inhibition of angiotensin II formation and bradykinin degradation in isolated hearts.
Schölkens BA; Linz W
Clin Exp Hypertens A; 1988; 10(6):1259-70. PubMed ID: 2975971
[TBL] [Abstract][Full Text] [Related]
10. Bradykinin-dependent cardioprotective effects of losartan against ischemia and reperfusion in rat hearts.
Zhu P; Zaugg CE; Hornstein PS; Allegrini PR; Buser PT
J Cardiovasc Pharmacol; 1999 May; 33(5):785-90. PubMed ID: 10226867
[TBL] [Abstract][Full Text] [Related]
11. Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors.
Linz W; Schölkens BA
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S83-90. PubMed ID: 1282635
[TBL] [Abstract][Full Text] [Related]
12. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats.
Liu YH; Yang XP; Sharov VG; Sigmon DH; Sabbath HN; Carretero OA
Hypertension; 1996 Jan; 27(1):7-13. PubMed ID: 8591891
[TBL] [Abstract][Full Text] [Related]
13. Taurine protects the heart from neutrophil-induced reperfusion injury.
Raschke P; Massoudy P; Becker BF
Free Radic Biol Med; 1995 Oct; 19(4):461-71. PubMed ID: 7590395
[TBL] [Abstract][Full Text] [Related]
14. Preischaemic as well as postischaemic application of a calcium antagonist affords cardioprotection in the isolated guinea pig heart.
Massoudy P; Becker BF; Seligmann C; Gerlach E
Cardiovasc Res; 1995 Apr; 29(4):577-82. PubMed ID: 7796453
[TBL] [Abstract][Full Text] [Related]
15. ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts.
Linz W; Wiemer G; Schölkens BA
J Mol Cell Cardiol; 1992 Aug; 24(8):909-19. PubMed ID: 1331474
[TBL] [Abstract][Full Text] [Related]
16. [ACE inhibition: mechanisms of "cardioprotection" in acute myocardial ischemia].
Schölkens BA; Linz W
Klin Wochenschr; 1991; 69 Suppl 24():1-5. PubMed ID: 1865630
[TBL] [Abstract][Full Text] [Related]
17. Ramiprilat attenuates the local release of noradrenaline in the ischemic myocardium.
Carlsson L; Abrahamsson T
Eur J Pharmacol; 1989 Jul; 166(2):157-64. PubMed ID: 2792189
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotective effects of the aminopeptidase P inhibitor apstatin: studies on ischemia/reperfusion injury in the isolated rat heart.
Erşahin C; Euler DE; Simmons WH
J Cardiovasc Pharmacol; 1999 Oct; 34(4):604-11. PubMed ID: 10511138
[TBL] [Abstract][Full Text] [Related]
19. Possible protective effects of kinins and converting enzyme inhibitors in cardiovascular tissues.
Nolly H; Miatello R; Damiani MT; Abate CD
Immunopharmacology; 1997 Jun; 36(2-3):185-91. PubMed ID: 9228545
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin.
Gohlke P; Linz W; Schölkens BA; Kuwer I; Bartenbach S; Schnell A; Unger T
Hypertension; 1994 Apr; 23(4):411-8. PubMed ID: 8144208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
